In Summer 2018, we spoke to Adriano Antonio Treve, then general manager of Roche Turkey, now Area Head Central Eastern Europe, Turkey, Russia, Central Asia, Iran, Pakistan & Indian Subcontinent.
Treve provided insights into the main opportunities and challenges of the Turkish market, Roche’s unrivalled commitment to making a difference to patients’ lives as well as the company's phenomenal capacity to manage transitional phases throughout his career at Roche, spanning past 33 years, while the latter today faces the two-fold mission to successfully launch its groundbreaking new medicines and resist biosimilar competition on the oncology side.
As an industry, we understand the necessity to ensure the financial sustainability of the Turkish model of healthcare, but I hope that we can meet on common grounds with the authorities to find a healthier balance on pricing issues
